May 13, 2025: Microbiome-Targeting Therapy MaaT033 Continues to Show Promise in Final Phase 1 Readout - Neurology Live - MaaT Pharma

To read the article, click here!

Previous PostMay 13, 2025: MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2025
Next PostMay 12, 2025: 3 Questions à MaaT Pharma - Direct Dirigeants (subtitled in English)

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club